These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4392612)

  • 1. Maternal modification of tissue antigenicity and the graft-versus-host reaction.
    Uphoff DE
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):84-7. PubMed ID: 4392612
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue.
    Bennett M
    Transplantation; 1971 Feb; 11(2):158-69. PubMed ID: 4397088
    [No Abstract]   [Full Text] [Related]  

  • 3. Maternal modification of antigen recognition in the ova-transfer substrain R3eB.
    Uphoff DE
    J Natl Cancer Inst; 1972 Feb; 48(2):517-22. PubMed ID: 4405705
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal modification of antigenicity: an immunologic mechanism to ensure survival of mammalian fetuses.
    Uphoff DE
    J Natl Cancer Inst; 1970 Dec; 45(6):1189-96. PubMed ID: 4922674
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-host reaction modified by in vitro preincubation of marrow with subcellular antigen.
    Uphoff DE; Draper LR
    J Natl Cancer Inst; 1971 Jan; 46(1):139-41. PubMed ID: 4396090
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal-fetal interactions and histocompatibility antigen polymorphisms.
    Palm J
    Transplant Proc; 1970 Mar; 2(1):162-73. PubMed ID: 4398946
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of host-versus-graft and graft-versus-host reactions on the immune response of mice to sheep red blood cells.
    Zaleski M
    Folia Biol (Praha); 1971; 17(2):111-22. PubMed ID: 4396932
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E
    Exp Hematol; 1977 May; 5(3):215-35. PubMed ID: 326573
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic competence of bone marrow of different genotypes.
    Uphoff DE
    J Natl Cancer Inst; 1969 Nov; 43(5):1055-66. PubMed ID: 4390909
    [No Abstract]   [Full Text] [Related]  

  • 11. The Graft-versus-Host Reaction: a pathogenetic mechanism of experimental and human disease.
    Seemayer TA
    Perspect Pediatr Pathol; 1979; 5():93-136. PubMed ID: 43960
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
    Halle-Pannenko O; Martyre MC; Mathé G
    Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms in graft-versus-host reactions: an immunogenetic appraisal.
    Uphoff DE
    Transplant Proc; 1976 Dec; 8(4):515-9. PubMed ID: 11581
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft-versus-host reactions in bone marrow transplantation.
    Meuwissen HJ; Kersey J; Pabst H; Gatti R; Chilgren R; Good RA
    Transplant Proc; 1971 Mar; 3(1):414-7. PubMed ID: 4398498
    [No Abstract]   [Full Text] [Related]  

  • 15. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
    Nouza K; Haskovcová H; Nĕmec M
    Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of cell separation techniques and isantibody to host antigens in the treatent of severe combined immunodeficiency disease with HL-A incompatible maternal marrow.
    Gelfand EW; Phillips RA; Miller RG; McCulloch EA; Rosen FS
    Exp Hematol; 1974; 2(3):122-30. PubMed ID: 4156326
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 18. Graft-versus-host inhibition. 3. Fetal thymic factor and fetal liver cells to minimize secondary disease.
    Bortin MM; Rimm AA
    Transplantation; 1970 Mar; 9(3):310-21. PubMed ID: 4392382
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increased efficacy of allogenic bone marrow transplantation].
    Fedotenkov AG; Danilova LA; Ignasheva LP
    Biull Eksp Biol Med; 1982 Aug; 94(8):104-8. PubMed ID: 6751429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histological studies on graft versus host reaction in the mouse after treating the donor animal with antilymphocyte serum].
    Beil E; Becker G; Thierfelder S; Mempel W; Rodriguez E
    Verh Dtsch Ges Pathol; 1970; 54():191-7. PubMed ID: 4104529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.